Caplyta Drug Interactions: 165 Major, 320 Moderate
Caplyta (Lumateperone) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Caplyta. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Lumateperone.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Lumateperone.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Lumateperone is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Lumateperone.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Lumateperone is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Lumateperone.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Lumateperone.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Lumateperone.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Lumateperone is combined with Aceclofenac.
Level 2 evidence
Acetazolamide
The risk or severity of CNS depression can be increased when Acetazolamide is combined with Lumateperone.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Lumateperone.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Lumateperone.
Level 2 evidence
Enter your NPI to unlock 15 major interactions for Caplyta
Caplyta (Lumateperone) has 497 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Caplyta (Lumateperone) has 165 major, 320 moderate, and 12 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Caplyta. Always confirm against the full prescribing information.